Preclinical Studies in Pluripotent Stem Cell-Derived Myogenic Progenitors to Enable a First-in-Human Phase 1 Safety/Dose Escalation Trial for Duchenne Muscular Dystrophy

Project: Research project

Description

Preclinical Studies in Pluripotent Stem Cell-Derived Myogenic Progenitors to Enable a First-in-Human Phase 1 Safety/Dose Escalation Trial for Duchenne Muscular Dystrophy
StatusActive
Effective start/end date9/15/198/31/21

Funding

  • DUCHENNE UK

Fingerprint

Pluripotent Stem Cells
Duchenne Muscular Dystrophy
Safety